Nemaura medical inc. (NMRD)
Balance Sheet / Quarterly
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
ASSETS
Current Assets:
Cash

-

-

-

-

5,040

526

319

-

1,664

597

1,284

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash

1,067

1,771

3,068

3,740

-

-

-

822

-

-

-

911

7,593

8,318

8,494

9,403

9,851

99

125

354

613

907

1,111

1,873

Fixed rate cash account

-

-

-

-

0

3,260

4,621

4,911

4,789

1,350

1,294

1,867

-

-

-

0

-

-

-

-

-

-

-

-

Restricrted Cash, Current

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

94

-

Prepaid expenses and other receivables

443

375

552

736

440

180

304

187

109

71

65

51

67

55

106

148

70

78

158

164

39

50

64

20

Accrued interest receivable

-

-

-

-

0

71

81

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest receivable

-

-

-

-

-

-

-

77

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Inventory (raw materials)

229

195

38

38

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepayment to related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

69

247

465

510

561

0

Total current assets

1,741

2,343

3,659

4,515

5,481

4,038

5,327

5,998

6,563

2,020

2,645

2,830

7,660

8,374

8,600

9,552

9,921

178

353

766

1,118

1,467

1,832

1,893

Other Assets:
Property and equipment, net of accumulated depreciation

192

162

123

56

43

3

4

5

6

7

8

9

10

11

6

7

8

20

-

13

-

-

-

0

Intangible assets, net of accumulated amortization

229

197

192

191

223

232

240

251

231

232

220

203

191

204

189

172

171

180

-

133

115

91

71

70

Deferred offering costs

-

-

-

-

-

108

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other assets

422

360

316

248

266

344

244

256

238

239

228

212

-

-

-

180

-

-

-

-

6

6

-

-

Fixed rate cash account

-

-

-

-

-

-

-

-

0

4,735

4,532

4,358

-

-

-

0

-

-

-

-

-

-

-

-

Restricted Cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

85

Total Noncurrent Assets

-

-

-

-

-

-

-

-

-

-

-

-

201

216

196

-

180

201

198

146

122

97

71

156

Total assets

2,163

2,703

3,975

4,763

5,748

4,382

5,572

6,255

6,802

6,995

7,406

7,401

7,861

8,590

8,797

9,732

10,102

379

551

913

1,240

1,565

1,904

2,049

LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
Accounts Payable

183

214

176

161

205

54

140

49

65

142

97

77

44

49

93

73

61

30

96

66

50

138

105

1

Liability due to related parties

702

1,006

1,072

964

918

642

757

613

826

507

812

687

820

717

645

494

485

310

55

55

-

-

-

0

Other Liabilities and accrued expenses

191

54

140

107

188

331

240

77

162

144

137

87

117

92

138

90

45

202

176

0

4

8

10

6

Deferred revenue

66

61

36

65

98

97

66

70

-

-

-

-

-

-

-

-

-

-

38

-

-

-

-

-

Total current liabilities

1,143

1,336

1,426

1,298

1,410

1,126

1,204

811

1,054

794

1,046

852

983

859

877

658

592

543

367

122

54

147

115

8

Deferred revenue

-

-

-

-

1,181

1,206

1,254

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

170

-

-

-

0

Non-current portion of deferred revenue

1,254

1,170

1,240

1,237

-

-

-

1,333

1,249

1,272

1,197

1,183

1,177

1,258

1,265

1,396

1,521

1,564

1,516

1,538

1,566

1,664

1,687

1,667

Liabilities, Noncurrent

-

-

-

-

-

-

-

-

1,249

1,272

1,197

1,183

1,177

1,258

1,265

1,396

1,521

1,564

1,516

1,708

1,566

1,664

1,687

1,667

Total liabilities

2,398

2,507

2,667

2,536

2,592

2,332

2,458

2,144

2,304

2,067

2,244

2,035

2,161

2,118

2,142

2,054

2,113

2,108

1,883

1,830

1,621

1,811

1,803

1,675

Commitments and contingencies

-

-

-

-

-

-

0

-

-

-

-

-

0

0

0

-

0

-

0

0

-

-

-

-

Stockholders' Equity:
Series A convertible preferred stock, $0.001 par value, 200,000 shares authorized; 0 and 137,324 outstanding at March 31, 2019 and March 31, 2018, respectively.

-

-

-

-

0

0

0

0

0

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Common stock, $0.001 par value, 42,000,000 shares authorized and 20,808,348 and 20,765,592 shares issued and outstanding at December 31, 2019 and March 31, 2019, respectively

20

208

208

20

207

205

205

67

67

205

205

205

205

205

205

205

205

200

200

200

200

200

200

200

Additional paid in capital

-

-

-

-

15,102

13,034

12,919

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Additional paid in capital

16,372

16,145

16,133

15,971

-

-

-

13,056

13,056

12,919

12,919

12,919

12,919

12,919

12,919

12,919

12,919

2,924

2,924

2,924

2,924

2,924

2,924

2,924

Accumulated deficit

-16,239

-15,794

-14,677

-13,425

-11,801

-10,875

-9,736

-8,973

-8,419

-7,953

-7,560

-7,152

-6,793

-6,418

-6,095

-5,601

-5,183

-4,854

-4,464

-4,061

-3,525

-3,367

-3,011

-2,741

Accumulated other comprehensive loss

-388

-363

-355

-339

-352

-313

-275

-40

-206

-243

-402

-605

-630

-234

-374

155

47

1

8

19

20

-4

-12

-8

Total stockholders' (deficit) equity

-234

196

1,308

2,226

3,156

2,050

3,113

4,110

4,498

4,927

5,161

5,366

5,700

6,472

6,654

7,678

7,988

-1,728

-1,331

-917

-380

-246

100

373

Total liabilities and stockholders' equity

2,163

2,703

3,975

4,763

5,748

4,382

5,572

6,255

6,802

6,995

7,406

7,401

7,861

8,590

8,797

9,732

10,102

379

551

913

1,240

1,565

1,904

2,049